|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The role of radiotherapy in localised and locally advanced prostate cancer显示文摘For a patient suffering from non-metastatic prostate cancer,the individualized recommendation of radiotherapy has to be the fruit of a multidisciplinary approach in the context of a Tumor Board,to be explained carefully to the patient to obtain his informed consent.External beam radiotherapy is now delivered by intensity modulated radiotherapy,considered as the gold standard.From a radiotherapy perspective,low-risk localized prostate cancer is treated by image guided intensity modulated radiotherapy,or brachytherapy if patients meet the required eligibility criteria.Intermediate-risk patients may benefit from intensity modulated radiotherapy combined with 4e6 months of androgen deprivation therapy;intensity modulated radiotherapy alone or combined with brachytherapy can be offered to patients unsuitable for androgen deprivation therapy due to co-morbidities or unwilling to accept it to preserve their sexual health.High-risk prostate cancer,i.e.high-risk localized and locally advanced prostate cancer,requires intensity modulated radiotherapy with long-term(≥2 years)androgen deprivation therapy with luteinizing hormone releasing hormone agonists.Post-operative irradiation,either immediate or early deferred,is proposed to patients classified as pT3pN0,based on surgical margins,prostate-specific antigen values and quality of life.Whatever the techniques and their degree of sophistication,quality assurance plays a major role in the management of radiotherapy,requiring the involvement of physicians,physicists,dosimetrists,radiation technologists and computer scientists.The patients must be informed about the potential morbidity of radiotherapy and androgen deprivation therapy and followed regularly during and after treatment for tertiary prevention and evaluation.A close cooperation is needed with general practitioners and specialists to prevent and mitigate side effects and maintain quality of life. | Michel Bolla Ann Henry Malcom Mason Thomas Wiegel | 2019 | Asian Journal of Urology2019，6，2： | 5 |
| 2 | Biomechanics of knee joint-- A review显示文摘现在的纸是知道工作怎么在膝的 biomechanics 的领域里被执行。各种各样的模型明确的表达被讨论并且进一步分类进数学模型,二维的模型和三维的模型。膝几何学是人的身体运动,膝看怎么各种各样,在不同飞机在并且怎么被看的关键部分胫骨和腿节上的力量行为被学习。它导致知道对膝关节起作用的力量。对各种各样的研究人员显示出的膝起作用的膝几何学和力量的试验性的研究被讨论了,并且结果的比较被做。另外,膝的静态、动态的分析也分别地被讨论了到某程度。 | Bhaskar Kumar MADETI Srinivasa Rao CHALAMALASETTI S. K. Sundara siva rao BOLLA PRAGADA | 2015 | Frontiers of Mechanical Engineering2015，10，2： | 4 |
| 3 | Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study显示文摘 | Jean-Fran?ois Bosset Gilles Calais Laurent Mineur Philippe Maingon Suzana Stojanovic-Rundic René-Jean Bensadoun Etienne Bardet Alexander Beny Jean-Claude Ollier Michel Bolla Dominique Marchal Jean-Luc Van Laethem Vincent Klein Jordi Giralt Pierre Clavère | 2014 | Lancet Oncology2014，，2： | 2 |
| 4 | 鹌鹑的饲养管理显示文摘 1 前言
鹌鹑是一种比较难饲养的禽,一般饲养在小笼子里.鹌鹑虽易感染普通禽病,但是具有相当的抵抗力.鹌鹑大约6周龄性成熟,通常在50日龄时达到高产期.只要管理适当,鹌鹑能够在产蛋第一年产200个蛋.生命周期为2~2.5年.
…… | Maurice Randall Gerry Bolla | 2007 | 中国家禽2007，29，21： | 2 |
| 5 | Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma:A Rare Cancer Network study显示文摘Objective: Primary uterine leiomyosarcomas(ULMS) are rare,and the optimal treatment is controversial.We aimed to assess the outcome and prognostic factors in a multicenter population of women treated for primary ULMS.Methods: We retrospectively collected data of 110 women treated in 19 institutions of the Rare Cancer Network(RCN).Inclusion criteria consisted of a pathology report confirming the diagnosis of ULMS,aged 18–80 years,complete International Federation of Gynecology and Obstetrics(FIGO) stage information,complete information on treatment,and a minimum follow-up of 6 months.Local control(LC) and locoregional control(LRC),overall survival(OS) and disease-free survival(DFS) rates were computed using the Kaplan-Meier method.Univariate analysis was implemented using the log rank test,and multivariate analysis using the Cox model.Results: All patients underwent surgery.Seventy-five patients(68%) received adjuvant radiotherapy(RT),including brachytherapy in 18(16%).Seventeen patients(15%) received adjuvant chemotherapy.Median follow-up was 58(range,6–240) months.Five-year OS and DFS rates were 50% and 34%,and LC and LRC rates were 88%and 72%,respectively.On multivariate analysis,independent favorable prognostic factors were younger age,FIGO stage I,small tumor size,previous uterine disease,and no vascular invasion for OS and DFS.FIGO stage was the only favorable factor influencing LRC.Adjuvant local or systemic treatments did not improve the outcomes.Eight patients treated with RT presented a grade 3 acute toxicity,and only one patient with grade 3 late toxicity.Conclusions: In this large population of primary ULMS patients,we found good results in terms of LC and LRC.Nevertheless,OS remains poor,mainly due to the occurrence of distant metastases.An early diagnosis seemed to improve the prognosis of the patients.Adjuvant local or systemic treatments,or more aggressive surgicalprocedures such as the Wertheim procedure,did not seem to impact the outcome. | Alessandra Franzetti Pellanda Berardino De Bari Elisabeth Deniaud-Alexandre MarcoKrengli Paul Van Houtte Antonella Riehetti Salvador Villa Hadassah Goldberg EwaSzutowiez-Zielifiska Michel Bolla Heidi Rutten Marc Van Eijkeren Philip Poortmans Guido Henke Yavuz Anaeak Steve Chan Christine Landmann Carine Kirkove LueianoScandolaro Jacques Bernier Rene-Olivier Mirimanof Mahmut Ozsahin | 2017 | Chinese Journal of Cancer Research2017，29，6： | 2 |
| 6 | Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis显示文摘 | John L. Wallace Stephanie Syer Emmanuel Denou Giada de Palma Linda Vong Webb McKnight Jennifer Jury Manlio Bolla Premysl Bercik Stephen M. Collins Elena Verdu Ennio Ongini | 2011 | Gastroenterology2011，，： | 2 |
| 7 | improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin 显示文摘 | Bolla M Gonzalez D Warde P | 1997 | N EngtJ Med1997，337，5： | 1 |
| 8 | Evaluation of maxillary molar distalization with the Distal-Jet:A comparison with other contemporary methods显示文摘 | Bolla E Muratore F Carano A | 2002 | Angle Orthod2002，72，6： | 1 |
| 9 | Effect of udder health status and lactation phase on the characteristics of Sardinian ewe milk 显示文摘 | Bianchi L Bolla A Budelli E | 2004 | J Dairy Sci2004，87，8： | 1 |
| 10 | Attraction of Bursaphelenchus xylophilus,pathotype MPS-1,to Monochamus carolinensis larvae显示文摘 | Bolla J A Bramble J Bolla R I | 1989 | Japan Journal of Nematology1989，19，： | 1 |
| 11 | Homocysteine and cognitive function in a population-based study of older adults显示文摘 | SCHAFER J H GLASS T A BOLLA K I | 2005 | J Am Geriatr Soc2005，53，13： | 1 |
| 12 | EAU Guidelines on Prostate Canc- er显示文摘 | Aus G Abbou CC Bolla M | 2005 | Euro Uro12005，48，： | 1 |
| 13 | A comprehensive tutorial for mobility management in data networks显示文摘 | Bolla R Repetto M | 2014 | IEEE Communications Surveys & Tutorials2014，16，2： | 1 |
| 14 | Mechanisms of fluoro- quinolone and macrolide resistance in Campylobacter spp 显示文摘 | Payot S Bolla J-M Corcoran D etal | 2006 | Microb Infect2006，8，： | 1 |
| 15 | Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer:long-term results of a randomised controlled trial(EORTC trial22911)显示文摘 | Bolla M van Poppel H Tombal B | 2012 | Lancet2012，380，9858： | 1 |
| 16 | Membrane permeability and regulation of drug 'influx and efflux' in enterobacterial pathogens显示文摘 | DAVIN-REGLI A BOLLA JM JAMES CE | 2008 | Curr Drug Targets2008，9，9： | 1 |
| 17 | Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin显示文摘 | Gonzalez D Warde P | 1997 | N Engl J Med1997，337，5： | 1 |
| 18 | Prostate cancer:On the road of progress显示文摘In Europe,prostate cancer(PCa)is the most frequently diagnosed cancer in men with an estimated 416000 new cases and the third leading cause of cancer death with 92000 deaths in 2012[1].In China,based on 177 of 234 cancer registries,PCa was the 7th most frequent neoplasm in men,with 49000 new cases in 2011[2].Of course the variability of the incidence of PCa has many causes,including environmental,dietary,lifestyle factors or genetic risks,with the well-known example of the higher incidence in African-American men compared to that of Caucasian men in the United States. | Michel Bolla René-Olivier Mirimanoff | 2019 | Asian Journal of Urology2019，6，2： | 1 |
| 19 | EAU guidelines on prostate cancer显示文摘 | Heidenreich A Aus G Bolla M | 2008 | Eur Urol2008，53，1： | 1 |
| 20 | EAU guidelines on pros- tate cancer显示文摘 | Heidenreich A Aus G Bolla M | 2008 | EurUrol2008，53，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员